Getinge AB (GETI B) - Product Pipeline Analysis, 2023 Update

Summary
Getinge AB (Getinge) is a medical technology company engaged in the designing, development and marketing of equipment and instruments in the areas related to surgery, infection control, intensive care, care ergonomics and wound care. Its major products include surgical tables, lights, ventilators, and anesthesia equipments, heart-lung machines with accompanying disposables, equipments and instruments for cardiac surgery, vascular surgery; cardiac assist devices; patient lifting devices, hospital beds, stretchers and couches, mattresses for treating and preventing pressure sores, disinfectors, sterilization equipments, and documentation systems and various other accessories. The company also provides various services related to hospitals and project implementations. The company has manufacturing facilities in France, China, Germany, Poland, Sweden, Turkey, Netherlands, UK and the US and sells its products through proprietary sales companies and network of distributors in over 133 countries. Getinge is headquartered in Gothenburg, Sweden.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developmentsThe report analyzes all pipeline products in development for the company Getinge ABThe report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch dateThe report provides detailed description of products in development, technical specification and functionsThe report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.Reasons to Buy:Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscapeDesign and develop your product development, marketing and sales strategies by understanding the competitor portfolioTo formulate effective Research & Development strategiesDevelop market-entry and market expansion strategiesExploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust returnPlan mergers and acquisitions effectively by identifying key players of the most promising pipelineIdentify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantageDevelop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etcIdentify, understand and capitalize the next high-value products that your competitor would add in its portfolioNote:Some sections may be missing if data is unavailable for the company